VAERS reports by lot

Merck Pneumococcal lot M038216: VAERS reports

65 VAERS reports list lot M038216 as a Merck Pneumococcal vaccine, received between 2016-10-27 and 2018-08-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
29%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction8239%
General / Systemic (non-local)2914%
Dermatological (non-injection-site)2412%
Allergic / Anaphylactic2110%
Musculoskeletal199%
Cardiac / Cardiovascular136%
Neurological105%
Gastrointestinal52%
Psychiatric / Neuropsychiatric31%
Respiratory21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida10
Pennsylvania5
Texas5
Illinois4
Ohio4
North Carolina4
Tennessee4
Georgia3
New York3
Missouri2
Alabama2
Massachusetts2

Reports by month received

2016-101
2016-118
2016-1214
2017-016
2017-023
2017-034
2017-041
2017-053
2017-066
2017-073
2017-081
2017-094
2017-106
2017-111
2017-121
2018-021
2018-051
2018-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.